Rick E Winningham

2017 - Theravance Biopharma

In 2017, Rick E Winningham earned a total compensation of $2.3M as Chief Executive Officer at Theravance Biopharma, a 63% decrease compared to previous year.

Compensation breakdown

Bonus$201,997
Non-Equity Incentive Plan$302,995
Salary$932,534
Stock Awards$874,720
Other$5,000
Total$2,317,245

Winningham received $932.5K in salary, accounting for 40% of the total pay in 2017.

Winningham also received $202K in bonus, $303K in non-equity incentive plan, $874.7K in stock awards and $5K in other compensation.

Rankings

In 2017, Rick E Winningham's compensation ranked 4,806th out of 14,666 executives tracked by ExecPay. In other words, Winningham earned more than 67.2% of executives.

ClassificationRankingPercentile
All
4,806
out of 14,666
67th
Division
Manufacturing
1,707
out of 5,770
70th
Major group
Chemicals And Allied Products
506
out of 2,074
76th
Industry group
Drugs
390
out of 1,730
78th
Industry
Pharmaceutical Preparations
309
out of 1,329
77th
Source: SEC filing on March 21, 2018.

Winningham's colleagues

We found four more compensation records of executives who worked with Rick E Winningham at Theravance Biopharma in 2017.

2017

Shehnaaz Suliman

Theravance Biopharma

Senior Vice President, Corporate Development and Strategy

2017

Bradford Shafer

Theravance Biopharma

General Counsel

2017

Renee Gala

Theravance Biopharma

Chief Financial Officer

2017

Frank Pasqualone

Theravance Biopharma

Senior Vice President and Global Head, Acute Care Business

News

You may also like